Replies to post #201176 on Biotech Values

[Bickema]

Fredric N Eshelman, a director of The Medicines Company, recently acquired 300,000 shares of the company. The buys took place at $33.68 per share, on May 12, 2016. Eshelman now owns 1,244,537 shares of the company. Eshelman operates out of Parsippany, NJ. Some additional info was provided as follows

[DewDiligence]

EGRX +4%—MDCO prevails in Angiomax en banc rehearing:

https://twitter.com/danravicher/status/752505994551369728

This is bullish for the commercial prospects of EGRX’s Kangio (pending FDA approval).